Indefinite Delivery Contract 75F40118D10029

The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) has awarded a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract, valued at up to $75,000,000.00, to Iqvia Government Solutions Inc. for the Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3). This contract aims to obtain large-scale, longitudinal healthcare data from the United States covering tens of millions of...

The Department of Health and Human Services Food and Drug Administration awarded multiple indefinite delivery contracts under the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ. Iqvia Government Solutions Inc. received two delivery orders totaling $20 million to provide data sources and products/services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY INITIATIVE #3 effort. Performance will take place in Mosby, Virginia over periods from September 2020 through...

The Indefinite Delivery Contract (IDC) with ID 75F40118D10032 was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative. The $75 million multiple-award contract aims to develop new and innovative methods for automated reporting of CBER-regulated biological products. Iqvia Government Solutions, a leading provider of healthcare data and analytics services to federal agencies, will deliver a range of...

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a multiple-award indefinite-delivery indefinite-quantity (IDIQ) contract for the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics. The prime contractor, The Lewin Group, Inc. (doing business as Lewing Group Inc.), a subsidiary of UnitedHealth Group Incorporated, will provide data sources containing administrative claims data or claims and electronic...

The Department of Health and Human Services Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract under the BEST (Biologics Effectiveness and Safety) Initiative to CVS Health Clinical Trial Services LLC, a subsidiary of CVS Health Corporation. The contract, with a $50 million ceiling value and performance period through September 2025, is for the procurement of data sources to support the FDA's surveillance of biologics. Two task orders have been awarded to date under this...

The key products and services being delivered under this federal contract IDV award are data sources and analytics to support the Food and Drug Administration's (FDA) Biologics Effectiveness and Safety (BEST) Initiative. The prime contractor, CVS Healthspire Payor & Life Sciences LLC, a subsidiary of CVS Health Corporation, was awarded a $50 million multiple award IDV to provide healthcare data and conduct safety analyses for the BEST program. Under a $1.38 million task order, CVS...

The Department of Health and Human Services Food and Drug Administration awarded a single award Blanket Purchase Agreement to Leidos, Inc. under the Multiple Award Schedule contract vehicle. With a potential value of $200 million and a period of performance through August 2024, the CBER IT SYSTEMS OPERATIONS AND MODERNIZATION BPA aims to procure IT systems operations and modernization services for the FDA's Center for Biologics Evaluation and Research. Under this BPA, Leidos will provide a range...

The U.S. Food and Drug Administration (FDA) awarded a $75 million multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to The Lewin Group, Inc. to support the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics. The contract has a 5-year ordering period and aims to obtain large-scale, longitudinal healthcare data from the United States covering tens of millions of patients, as well as access to full medical charts for patient data...

The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) has awarded a single-award Blanket Purchase Agreement (BPA) to Zen-Bio, Inc. (doing business as Zenbio), a for-profit manufacturer of human blood products located in Durham, North Carolina. The BPA, valued at $0.00 ceiling, is for the procurement of "BPA FOR BLOOD UNITS" to support the CDC's disease monitoring, prevention, and research efforts in Pittsburgh, Pennsylvania. Under this...

The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Core Human Factors, Inc. with a potential value of $10,000,000. The contract aims to procure comparative use human factors studies to assess the impact of differences between the user interfaces of generic drug-device combination products and their reference listed drugs. A firm fixed price delivery order for $1,035,113 was issued against this contract. Core Human...